Global Pharmaceutical Contract Sales Outsourcing Market
Global Pharmaceutical Contract Sales Outsourcing Market

Pharmaceutical Contract Sales Outsourcing Comprehensive Study by Type (Pharmaceutical Equipment’s, Finished Drugs), Services (Clinical Trials, Biomedical Research), End Users (Healthcare Organizations, Pharmaceutical Organizations), Sales Model (Dedicated Sales, Synthetic Sales) Players and Region - Global Market Outlook to 2026

Pharmaceutical Contract Sales Outsourcing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 203 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pharmaceutical Contract Sales Outsourcing Market Scope?
Pharmaceutical Corporations are increasingly outsourcing their services, to cut costs. Formulation development, analytical and testing services, API production, clinical trial management, and solid dose manufacturing are just a few of the services that are gaining traction among pharma companies. The coronavirus outbreak has dominated worldwide news for several months, putting pressure on the pharmaceutical CSO industry.

The Pharmaceutical Contract Sales Outsourcing market study is being classified by Type (Pharmaceutical Equipment’s and Finished Drugs) and major geographies with country level break-up.

The Pharma Contract Sales Outsourcing industry is segmented, but it is predicted to grow as an increase in customer awareness regarding healthcare products among other factors, drives the market forward. Industry Leaders are facing Stiff Competition from Anchen Pharmaceuticals, Cadila Pharmaceuticals, Cangene Corporation, Apotex. Companies are differentiating their products from the competition by employing innovative ways and technology. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Pharmaceutical Contract Sales Outsourcing market throughout the predicted period.

Ardena (Belgium), Natoli Engineering (United States), ARL Bio Pharma (United States), Charles River Laboratories (United States), PDI Pharmaceuticals (United States), MedPharm (United Kingdom), Ashfield (United Kingdom), inVentiv Health (United States), Granard Pharmaceutical (United States) and Vanguard Pharma Inc (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Realmeds (India), Albany molecular research (United States) and Catalytica Pharmaceuticals (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Pharmaceutical Contract Sales Outsourcing market by Type, Application and Region.

On the basis of geography, the market of Pharmaceutical Contract Sales Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In September 2021 Ardena released a Statement of Acquiring Idifarma from Suanfarma. Ardena's aim to become a leading global CDMO, offering integrated solutions across the whole pharma development lifecycle, is supported by the purchase from Suanfarma, which provides expansion across Southern Europe.



Influencing Market Trend
  • New Treatments are Increasingly being Outsourced to Developing Markets
  • Pharmaceutical Contract Sales Outsourcing is Benefiting from a Huge Rise in Pharmaceutical R&D

Market Drivers
  • Demand for Innovative Medications is Increasing to meet Unmet Clinical Requirements
  • The Increased Awareness of the Need of Boosting Customer Immune System

Opportunities
  • Changes in Customer Communication Habits and the Rise of Digital

Restraints
  • The Threat of Data Hacking

Challenges
  • Sales of Pharmaceuticals are Reliant on Doctor and Medical Professionals
  • Costs Incurred For Training, Recruiting the Sales Team


Key Target Audience
Venture and Capitalist, Healthcare Organization, Government and Research Organization, New Entrants/Investors, Analysts and Strategic Business Partners and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Pharmaceutical Contract Sales Outsourcing market expands?
The Global Pharmaceutical Contract Sales Outsourcing market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Pharmaceutical Contract Sales Outsourcing market?
The prominent players of Global Pharmaceutical Contract Sales Outsourcing market are Ardena (Belgium), Natoli Engineering (United States), ARL Bio Pharma (United States), Charles River Laboratories (United States), PDI Pharmaceuticals (United States), MedPharm (United Kingdom), Ashfield (United Kingdom), inVentiv Health (United States), Granard Pharmaceutical (United States) and Vanguard Pharma Inc (United States), to name a few.

3. What are the top priorities to focus for Pharmaceutical Contract Sales Outsourcing market’s growth?
In this highly competitive & fast evolving Pharmaceutical Contract Sales Outsourcing industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Pharmaceutical Equipment’s
  • Finished Drugs
By Services
  • Clinical Trials
  • Biomedical Research

By End Users
  • Healthcare Organizations
  • Pharmaceutical Organizations

By Sales Model
  • Dedicated Sales
  • Synthetic Sales

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Demand for Innovative Medications is Increasing to meet Unmet Clinical Requirements
      • 3.2.2. The Increased Awareness of the Need of Boosting Customer Immune System
    • 3.3. Market Challenges
      • 3.3.1. Sales of Pharmaceuticals are Reliant on Doctor and Medical Professionals
      • 3.3.2. Costs Incurred For Training, Recruiting the Sales Team
    • 3.4. Market Trends
      • 3.4.1. New Treatments are Increasingly being Outsourced to Developing Markets
      • 3.4.2. Pharmaceutical Contract Sales Outsourcing is Benefiting from a Huge Rise in Pharmaceutical R&D
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Contract Sales Outsourcing, by Type, Services, End Users, Sales Model and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Contract Sales Outsourcing (Value)
      • 5.2.1. Global Pharmaceutical Contract Sales Outsourcing by: Type (Value)
        • 5.2.1.1. Pharmaceutical Equipment’s
        • 5.2.1.2. Finished Drugs
      • 5.2.2. Global Pharmaceutical Contract Sales Outsourcing by: Services (Value)
        • 5.2.2.1. Clinical Trials
        • 5.2.2.2. Biomedical Research
      • 5.2.3. Global Pharmaceutical Contract Sales Outsourcing by: End Users (Value)
        • 5.2.3.1. Healthcare Organizations
        • 5.2.3.2. Pharmaceutical Organizations
      • 5.2.4. Global Pharmaceutical Contract Sales Outsourcing by: Sales Model (Value)
        • 5.2.4.1. Dedicated Sales
        • 5.2.4.2. Synthetic Sales
      • 5.2.5. Global Pharmaceutical Contract Sales Outsourcing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharmaceutical Contract Sales Outsourcing (Price)
      • 5.3.1. Global Pharmaceutical Contract Sales Outsourcing by: Type (Price)
  • 6. Pharmaceutical Contract Sales Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ardena (Belgium)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Natoli Engineering (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ARL Bio Pharma (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Charles River Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PDI Pharmaceuticals (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MedPharm (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ashfield (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. InVentiv Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Granard Pharmaceutical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vanguard Pharma Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmaceutical Contract Sales Outsourcing Sale, by Type, Services, End Users, Sales Model and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Contract Sales Outsourcing (Value)
      • 7.2.1. Global Pharmaceutical Contract Sales Outsourcing by: Type (Value)
        • 7.2.1.1. Pharmaceutical Equipment’s
        • 7.2.1.2. Finished Drugs
      • 7.2.2. Global Pharmaceutical Contract Sales Outsourcing by: Services (Value)
        • 7.2.2.1. Clinical Trials
        • 7.2.2.2. Biomedical Research
      • 7.2.3. Global Pharmaceutical Contract Sales Outsourcing by: End Users (Value)
        • 7.2.3.1. Healthcare Organizations
        • 7.2.3.2. Pharmaceutical Organizations
      • 7.2.4. Global Pharmaceutical Contract Sales Outsourcing by: Sales Model (Value)
        • 7.2.4.1. Dedicated Sales
        • 7.2.4.2. Synthetic Sales
      • 7.2.5. Global Pharmaceutical Contract Sales Outsourcing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharmaceutical Contract Sales Outsourcing (Price)
      • 7.3.1. Global Pharmaceutical Contract Sales Outsourcing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Contract Sales Outsourcing: by Type(USD Million)
  • Table 2. Pharmaceutical Contract Sales Outsourcing Pharmaceutical Equipment’s , by Region USD Million (2015-2020)
  • Table 3. Pharmaceutical Contract Sales Outsourcing Finished Drugs , by Region USD Million (2015-2020)
  • Table 4. Pharmaceutical Contract Sales Outsourcing: by Services(USD Million)
  • Table 5. Pharmaceutical Contract Sales Outsourcing Clinical Trials , by Region USD Million (2015-2020)
  • Table 6. Pharmaceutical Contract Sales Outsourcing Biomedical Research , by Region USD Million (2015-2020)
  • Table 7. Pharmaceutical Contract Sales Outsourcing: by End Users(USD Million)
  • Table 8. Pharmaceutical Contract Sales Outsourcing Healthcare Organizations , by Region USD Million (2015-2020)
  • Table 9. Pharmaceutical Contract Sales Outsourcing Pharmaceutical Organizations , by Region USD Million (2015-2020)
  • Table 10. Pharmaceutical Contract Sales Outsourcing: by Sales Model(USD Million)
  • Table 11. Pharmaceutical Contract Sales Outsourcing Dedicated Sales , by Region USD Million (2015-2020)
  • Table 12. Pharmaceutical Contract Sales Outsourcing Synthetic Sales , by Region USD Million (2015-2020)
  • Table 13. South America Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2015-2020)
  • Table 14. South America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 15. South America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 16. South America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 17. South America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 18. Brazil Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 19. Brazil Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 20. Brazil Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 21. Brazil Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 22. Argentina Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 23. Argentina Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 24. Argentina Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 25. Argentina Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 26. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 28. Rest of South America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 29. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 30. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 33. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 34. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 35. China Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 36. China Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 37. China Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 38. China Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 39. Japan Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 40. Japan Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 41. Japan Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 42. Japan Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 43. India Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 44. India Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 45. India Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 46. India Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 47. South Korea Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 48. South Korea Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 49. South Korea Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 50. South Korea Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 51. Taiwan Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 52. Taiwan Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 53. Taiwan Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 54. Taiwan Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 55. Australia Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 56. Australia Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 57. Australia Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 58. Australia Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 59. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 63. Europe Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2015-2020)
  • Table 64. Europe Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 65. Europe Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 66. Europe Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 67. Europe Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 68. Germany Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 69. Germany Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 70. Germany Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 71. Germany Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 72. France Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 73. France Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 74. France Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 75. France Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 76. Italy Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 77. Italy Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 78. Italy Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 79. Italy Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 80. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 81. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 82. United Kingdom Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 83. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 84. Netherlands Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 85. Netherlands Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 86. Netherlands Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 87. Netherlands Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 88. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 89. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 90. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 91. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 92. MEA Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2015-2020)
  • Table 93. MEA Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 94. MEA Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 95. MEA Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 96. MEA Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 97. Middle East Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 98. Middle East Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 99. Middle East Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 100. Middle East Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 101. Africa Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 102. Africa Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 103. Africa Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 104. Africa Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 105. North America Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2015-2020)
  • Table 106. North America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 107. North America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 108. North America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 109. North America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 110. United States Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 111. United States Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 112. United States Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 113. United States Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 114. Canada Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 115. Canada Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 116. Canada Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 117. Canada Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 118. Mexico Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2015-2020)
  • Table 119. Mexico Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2015-2020)
  • Table 120. Mexico Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2015-2020)
  • Table 121. Mexico Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2015-2020)
  • Table 122. Pharmaceutical Contract Sales Outsourcing: by Type(USD/Units)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Pharmaceutical Contract Sales Outsourcing: by Type(USD Million)
  • Table 134. Pharmaceutical Contract Sales Outsourcing Pharmaceutical Equipment’s , by Region USD Million (2021-2026)
  • Table 135. Pharmaceutical Contract Sales Outsourcing Finished Drugs , by Region USD Million (2021-2026)
  • Table 136. Pharmaceutical Contract Sales Outsourcing: by Services(USD Million)
  • Table 137. Pharmaceutical Contract Sales Outsourcing Clinical Trials , by Region USD Million (2021-2026)
  • Table 138. Pharmaceutical Contract Sales Outsourcing Biomedical Research , by Region USD Million (2021-2026)
  • Table 139. Pharmaceutical Contract Sales Outsourcing: by End Users(USD Million)
  • Table 140. Pharmaceutical Contract Sales Outsourcing Healthcare Organizations , by Region USD Million (2021-2026)
  • Table 141. Pharmaceutical Contract Sales Outsourcing Pharmaceutical Organizations , by Region USD Million (2021-2026)
  • Table 142. Pharmaceutical Contract Sales Outsourcing: by Sales Model(USD Million)
  • Table 143. Pharmaceutical Contract Sales Outsourcing Dedicated Sales , by Region USD Million (2021-2026)
  • Table 144. Pharmaceutical Contract Sales Outsourcing Synthetic Sales , by Region USD Million (2021-2026)
  • Table 145. South America Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2021-2026)
  • Table 146. South America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 147. South America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 148. South America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 149. South America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 150. Brazil Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 151. Brazil Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 152. Brazil Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 153. Brazil Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 154. Argentina Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 155. Argentina Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 156. Argentina Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 157. Argentina Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 158. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 159. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 160. Rest of South America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 161. Rest of South America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 162. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2021-2026)
  • Table 163. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 164. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 165. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 166. Asia Pacific Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 167. China Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 168. China Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 169. China Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 170. China Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 171. Japan Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 172. Japan Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 173. Japan Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 174. Japan Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 175. India Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 176. India Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 177. India Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 178. India Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 179. South Korea Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 180. South Korea Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 181. South Korea Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 182. South Korea Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 183. Taiwan Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 184. Taiwan Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 185. Taiwan Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 186. Taiwan Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 187. Australia Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 188. Australia Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 189. Australia Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 190. Australia Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 195. Europe Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2021-2026)
  • Table 196. Europe Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 197. Europe Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 198. Europe Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 199. Europe Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 200. Germany Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 201. Germany Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 202. Germany Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 203. Germany Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 204. France Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 205. France Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 206. France Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 207. France Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 208. Italy Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 209. Italy Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 210. Italy Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 211. Italy Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 212. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 213. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 214. United Kingdom Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 215. United Kingdom Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 216. Netherlands Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 217. Netherlands Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 218. Netherlands Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 219. Netherlands Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 220. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 221. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 222. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 223. Rest of Europe Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 224. MEA Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2021-2026)
  • Table 225. MEA Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 226. MEA Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 227. MEA Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 228. MEA Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 229. Middle East Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 230. Middle East Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 231. Middle East Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 232. Middle East Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 233. Africa Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 234. Africa Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 235. Africa Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 236. Africa Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 237. North America Pharmaceutical Contract Sales Outsourcing, by Country USD Million (2021-2026)
  • Table 238. North America Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 239. North America Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 240. North America Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 241. North America Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 242. United States Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 243. United States Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 244. United States Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 245. United States Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 246. Canada Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 247. Canada Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 248. Canada Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 249. Canada Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 250. Mexico Pharmaceutical Contract Sales Outsourcing, by Type USD Million (2021-2026)
  • Table 251. Mexico Pharmaceutical Contract Sales Outsourcing, by Services USD Million (2021-2026)
  • Table 252. Mexico Pharmaceutical Contract Sales Outsourcing, by End Users USD Million (2021-2026)
  • Table 253. Mexico Pharmaceutical Contract Sales Outsourcing, by Sales Model USD Million (2021-2026)
  • Table 254. Pharmaceutical Contract Sales Outsourcing: by Type(USD/Units)
  • Table 255. Research Programs/Design for This Report
  • Table 256. Key Data Information from Secondary Sources
  • Table 257. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Contract Sales Outsourcing: by Type USD Million (2015-2020)
  • Figure 5. Global Pharmaceutical Contract Sales Outsourcing: by Services USD Million (2015-2020)
  • Figure 6. Global Pharmaceutical Contract Sales Outsourcing: by End Users USD Million (2015-2020)
  • Figure 7. Global Pharmaceutical Contract Sales Outsourcing: by Sales Model USD Million (2015-2020)
  • Figure 8. South America Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 10. Europe Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 11. MEA Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 12. North America Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 13. Global Pharmaceutical Contract Sales Outsourcing: by Type USD/Units (2015-2020)
  • Figure 14. Global Pharmaceutical Contract Sales Outsourcing share by Players 2020 (%)
  • Figure 15. Global Pharmaceutical Contract Sales Outsourcing share by Players (Top 3) 2020(%)
  • Figure 16. Global Pharmaceutical Contract Sales Outsourcing share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Ardena (Belgium) Revenue, Net Income and Gross profit
  • Figure 19. Ardena (Belgium) Revenue: by Geography 2020
  • Figure 20. Natoli Engineering (United States) Revenue, Net Income and Gross profit
  • Figure 21. Natoli Engineering (United States) Revenue: by Geography 2020
  • Figure 22. ARL Bio Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 23. ARL Bio Pharma (United States) Revenue: by Geography 2020
  • Figure 24. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Charles River Laboratories (United States) Revenue: by Geography 2020
  • Figure 26. PDI Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 27. PDI Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 28. MedPharm (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. MedPharm (United Kingdom) Revenue: by Geography 2020
  • Figure 30. Ashfield (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Ashfield (United Kingdom) Revenue: by Geography 2020
  • Figure 32. InVentiv Health (United States) Revenue, Net Income and Gross profit
  • Figure 33. InVentiv Health (United States) Revenue: by Geography 2020
  • Figure 34. Granard Pharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 35. Granard Pharmaceutical (United States) Revenue: by Geography 2020
  • Figure 36. Vanguard Pharma Inc (United States) Revenue, Net Income and Gross profit
  • Figure 37. Vanguard Pharma Inc (United States) Revenue: by Geography 2020
  • Figure 38. Global Pharmaceutical Contract Sales Outsourcing: by Type USD Million (2021-2026)
  • Figure 39. Global Pharmaceutical Contract Sales Outsourcing: by Services USD Million (2021-2026)
  • Figure 40. Global Pharmaceutical Contract Sales Outsourcing: by End Users USD Million (2021-2026)
  • Figure 41. Global Pharmaceutical Contract Sales Outsourcing: by Sales Model USD Million (2021-2026)
  • Figure 42. South America Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 43. Asia Pacific Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 44. Europe Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 45. MEA Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 46. North America Pharmaceutical Contract Sales Outsourcing Share (%), by Country
  • Figure 47. Global Pharmaceutical Contract Sales Outsourcing: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Ardena (Belgium)
  • Natoli Engineering (United States)
  • ARL Bio Pharma (United States)
  • Charles River Laboratories (United States)
  • PDI Pharmaceuticals (United States)
  • MedPharm (United Kingdom)
  • Ashfield (United Kingdom)
  • inVentiv Health (United States)
  • Granard Pharmaceutical (United States)
  • Vanguard Pharma Inc (United States)
Additional players considered in the study are as follows:
Realmeds (India) , Albany molecular research (United States) , Catalytica Pharmaceuticals (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation